Emcure Pharma's Sanand Facility Clears USFDA Inspection With No Observations

Emcure Pharmaceuticals Ltd. on Wednesday said the US Food and Drug Administration has concluded a pre-approval inspection at its manufacturing facility in Sanand, Ahmedabad, without any observations.

The inspection was conducted from June 30 to July 8, the company said in an exchange filing.